Companies / Egypt
Egypt's Drugmakers Endure Tough Price Regime
January 2006 | Company Finance AlertLow spending on R&D continues to blight the pharmaceutical industry in Egypt and continues to curtail sector development, claim market observers. The problem lies mainly in the country's strict market controls, with Egypt's retail drug prices among the lowest in the Middle East.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.



